Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum Effective Volume of Ropivacaine for Infraclavicular Block
NCT01493986Phase 4Completed
- Sponsor
- University Hospital of North Norway
- Start
- Feb 2012
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in pain, sponsored by University Hospital of North Norway. Started Feb 2012; status: completed.
02
Drugs
ropivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT01493986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493986.